Indo US Bio-Tech (NSE:INDOUS) 9-Day RSI: 44.93 (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDOUS Indo US Bio-Tech Ltd NSE:INDOUS
64 GF Score
Price ₹86.93
GF Value ₹314.31
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Indo US Bio-Tech 9-Day RSI?

Indo US Bio-Tech NSE:INDOUS +0.32% 64 9-Day RSI is 44.93 as of Jul. 24, 2026. GuruFocus rates NSE:INDOUS with a GF Score™ of 64/100 and a GF Value™ of ₹314.31 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 274 Agriculture companies, Indo US Bio-Tech ranks better than 67.15% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-24), Indo US Bio-Tech's 9-Day RSI is 44.93.

The industry rank for Indo US Bio-Tech's 9-Day RSI or its related term are showing as below:

NSE:INDOUS's 9-Day RSI is ranked better than
67.15% of 274 companies
in the Agriculture industry
Industry Median: 47.9 vs NSE:INDOUS: 44.93

Indo US Bio-Tech  (NSE:INDOUS) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Indo US Bio-Tech 9-Day RSI Related Terms


NSE:INDOUS vs CTVA, CF, MOS: 9-Day RSI Comparison

For the Agricultural Inputs subindustry, Indo US Bio-Tech's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo US Bio-Tech 9-Day RSI vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's 9-Day RSI falls into.


NSE:INDOUS
64GF Score
Indo US Bio-Tech Ltd NSE:INDOUS
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo US Bio-Tech  (NSE:INDOUS) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 44.93 mean?
Indo US Bio-Tech (NSE:INDOUS) has a 9-Day RSI of 44.93 as of Jul. 24, 2026. According to the industry distribution chart, Indo US Bio-Tech ranks #90 out of 274 companies in the Agriculture industry, placing it in the top 32.8%.
Is Indo US Bio-Tech's 9-Day RSI too high?
Indo US Bio-Tech's current 9-Day RSI is 44.93. The Agriculture industry median 9-Day RSI is 47.90. Indo US Bio-Tech's value of 44.93 is 6.2% below this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #90 out of 274 companies in the Agriculture industry, which is above the industry midpoint. Overall, Indo US Bio-Tech has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's 9-Day RSI compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #90 out of 274 companies for 9-Day RSI. This puts Indo US Bio-Tech in the upper half of its industry. The industry median 9-Day RSI is 47.90. Indo US Bio-Tech's value of 44.93 is 6.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for an Agriculture company?
The median 9-Day RSI among Agriculture companies is 47.90, based on 274 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current 9-Day RSI of 44.93 is 6.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Agriculture industry, the median 9-Day RSI is 47.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current 9-Day RSI is 44.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹314.31, compared to a current price of ₹86.93 — trading 72.3% below its estimated fair value. The current 9-Day RSI is 44.93 and 6.2% below the Agriculture industry median of 47.90. Indo US Bio-Tech's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current 9-Day RSI is 44.93 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?

Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued. The current stock price of ₹86.93 is trading 72.3% below its estimated GF Value™ of ₹314.31. GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.

Key valuation signals for NSE:INDOUS:

  • 9-Day RSI: 44.93
  • GF Value™: ₹314.31 vs. price of ₹86.93 (72.3% below fair value)
  • GF Score™: 64/100 with 5 warning signs
  • Industry Position: 6.2% below the Agriculture median (#90 of 274)

No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Indo US Bio-Tech Business Description

Other Exchanges 541304:India
Address Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
64GF Score

Get the complete analysis for NSE:INDOUS

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹86.93
Price
₹314.31
GF Value